Professor, Department of Obstetrics and Gynaecology ; Deputy Director, Prenatal Genetic Diagnosis Centre, CUHK; Director, Pre-implantation Genetic Diagnosis Laboratory, CUHK
BIOGRAPHY
Event Date & Time
Date: April 22, 2021
Time: 10:00am (CEST), 4:00pm (CST)
Abstract
Advancements in technologies have revolutionized the genetic landscape. Chromosomal microarray analysis (CMA) becomes a proven method and is implemented to detect gains and losses of DNA and absence of heterozygosity across the genome. Next-generation sequencing technologies have brought opportunities and challenges to genetic testing, its prenatal application is an emerging field. We describe our experience using FetalChip, a CMA for prenatal research developed in our laboratory and describe the role of CMA in the era of genome sequencing.
Learning Objectives
- The role of chromosomal microarray analysis (CMA) in prenatal genetic clinical research.
- CMA is a well-established and proven technology to identify pathogenic CNVs
- The utility of genome sequencing
For Research Use Only. Not for use in diagnostic procedures.
Webinars will be available for unlimited on-demand viewing after live event.
You May Also Like
DEC 16, 2025 | 8:00 AM
Starting Soon!
Currently, the process for microbial identification research in many laboratories involves a combination of culture, PCR, and either send-out or in-house sequencing-based testing – oft...
DEC 17, 2025 | 8:00 AM
C.E. CREDITS
Parkinson’s disease (PD) remains one of the most challenging neurodegenerative disorders to diagnose and monitor. Conventional clinical assessments and imaging often miss the early mol...
DEC 18, 2025 | 8:00 AM
Immunotherapy has transformed cancer treatment, but persistent challenges, such as T cell exhaustion, limited persistence, and variability in response, continue to impact therapeutic success...
JAN 14, 2026 | 10:00 AM
Join us for an insightful webinar to discuss a holistic approach to testing for TB in a clinical setting. Tuberculosis remains a global health challenge and accurate, timely diagnosis is cri...
JAN 15, 2026 | 8:00 AM
Personalized medicine promises to significantly improve patient outcomes, but achieving this requires a deep understanding of human health and disease mechanisms at the molecular level. The...
JAN 19, 2026 | 8:45 AM
C.E. CREDITS
Lipid nanoparticles (LNPs) have become the gold standard in non-viral gene delivery technologies, exemplified by the approval of the LNP messenger RNA (mRNA) vaccines against SARS-CoV-2. Sin...
Loading Comments...